N6-methyladenosine RNA modification is associated with enzalutamide resistance in prostate cancer (RNA-seq)
Our study examines the role of m6A RNA modification in regulating gene expression of transcripts promoting enzalutamide resistance in prostate cancer. Overall design: RNA-seq of C4-2B vs MDVR PC cell lines in 4 replicates (includes input ctrl and MeRIP samples)